Colorectal Cancer Trial, Recruiting NCT05663203 Sponsor: Emory University Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT05663203
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

  • Adults aged 18 or older
  • Have been diagnosed with colorectal cancer
  • Expected to live for more than 12 months
  • Currently receiving chemotherapy treatment
  • Are experiencing at least two symptoms affecting mood, thinking, or energy (such as fatigue, depression, anxiety, or cognitive difficulties), based on set symptom thresholds
  • Have a primary caregiver — a family member or close person who provides their main emotional and physical support
  • Have access to the internet
  • Are fluent in English

For caregivers:

  • Adults aged 18 or older
  • Are the primary caregiver for a patient in the trial
  • Have access to the internet
  • Are fluent in English

Who may not be able to join:

For patients:

  • People whose physical functioning is significantly limited, based on a medical scoring scale called the Karnofsky Performance Scale (confirm with trial site for exact threshold)

For caregivers:

  • People who have a serious health condition of their own, such as cancer or heart disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yufen Lin, PhD, RN, Emory University Hospital/Winship Cancer Institute

Phone: 404-712-9823

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 May 2023
Est. completion
1 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Attrition Rate; Adherence Rate; Acceptability Rate; Multidimensional Fatigue Inventory; Patient Health Questionnaire; Pittsburgh Sleep Quality Index; Brief Pain Inventory; Attentional Function Index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov